Mohammad Sayem

Mohammad Sayem

Auto-generated profile, based on publicly available information

Mohammad Sayem

Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka 1000, Bangladesh

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2025 in Medicine
Verified
Journal Article
Open access
ANAbdullah Al Noman
Abdullah Al Noman
ASAbdullah Al Saba
Abdullah Al Saba
MSMohammad Sayem
Mohammad Sayem
TYTahirah Yasmin
Tahirah Yasmin
ANA. H. M. Nurun Nabi
A. H. M. Nurun Nabi
Breast cancer, a major health concern worldwide, involves diverse molecular subtypes and complex gene expression patterns. This study conducted a comprehensive bioinformatics analysis of breast cancer, analyzing 10 gene expression datasets from the Gene Expression Omnibus archive to find common genes that exhibit differential expression (DEGs). Then, we conducted pan-cancer and functional enrichment analyses, including single-cell level investigations of DEGs. To identify potential hub genes, we built protein–protein interaction networks, which were further analyzed for methylation patterns and expression in various cancer stages. The study also explored interactions between these hub genes with microRNAs and transcription factors, along with their correlation with cytokine expression and infiltration of immune cells in the tumor microenvironment. The TCGA BRCA dataset was used for hub gene survival analysis. Key findings include the identification of 36 shared DEGs, with distinct expression patterns in principal component analysis, suggesting their potential as molecular signatures for diagnosis and prognosis. Investigation at the single-cell level revealed upregulated DEGs mainly expressed by tumor-associated fibroblast cells. Gene ontology unveiled upregulated genes mainly involved in the extracellular matrix, but most of the downregulated genes are tumor suppressors. The protein–protein interaction network analysis highlighted 7 hub genes: CAV1 , FN1 , BGN , CXCL12 , SPTBN1 , COL11A1 , and INHBA . Methylation analysis revealed intricate epigenetic regulation of these genes. MicroRNA and transcription factor interaction analysis underscored the complex regulatory networks influencing gene expression. Cytokine profile analysis in tumor microenvironment and its correlation with hub gene expression provided insights into the immunological landscape of breast cancer. Survival analysis indicated that both upregulated and downregulated hub genes are linked with patient overall survival outcomes, although it is not statistically significant. This study provides a detailed view of the underlying molecular mechanisms in breast cancer, suggesting potential biomarkers and therapeutic targets. Its findings can contribute significantly to understanding the complexity of the breast cancer microenvironment, leading to the development of more sophisticated and targeted treatment strategies.

6 September 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RTRifah Rownak Tanshee
Rifah Rownak Tanshee
ZMZimam Mahmud
Zimam Mahmud
ANA H M Nurun Nabi
A H M Nurun Nabi
MSMohammad Sayem
Mohammad Sayem
The Regulator of Telomere Helicase 1 (RTEL1) gene encodes a critical DNA helicase intricately involved in the maintenance of telomeric structures and the preservation of genomic stability. Germline mutations in the RTEL1 gene have been clinically associated with Hoyeraal-Hreidarsson syndrome, a more severe version of Dyskeratosis Congenita. Although various research has sought to link RTEL1 mutations to specific disorders, no comprehensive investigation has yet been conducted on missense mutations. In this study, we attempted to investigate the functionally and structurally deleterious coding and non-coding SNPs of the RTEL1 gene using an in silico approach. Initially, out of 1392 nsSNPs, 43 nsSNPs were filtered out through ten web-based bioinformatics tools. With subsequent analysis using nine in silico tools, these 43 nsSNPs were further shortened to 11 most deleterious nsSNPs. Furthermore, analyses of mutated protein structures, evolutionary conservancy, surface accessibility, domains & PTM sites, cancer susceptibility, and interatomic interaction revealed the detrimental effect of these 11 nsSNPs on RTEL1 protein. An in-depth investigation through molecular docking with the DNA binding sequence demonstrated a striking change in the interaction pattern for F15L, M25V, and G706R mutant proteins, suggesting the more severe consequences of these mutations on protein structure and functionality. Among the non-coding variants, two had the highest likelihood of being regulatory variants, whereas one variant was predicted to affect the target region of a miRNA. Thus, this study lays the groundwork for extensive analysis of RTEL1 gene variants in the future, along with the advancement of precision medicine and other treatment modalities.

5 July 2022 in Bulletin of the National Research Centre
Verified
Journal Article
Open access
PDF file
Saruar AlamSaruar Alam
Saruar Alam
MSMohammad Sayem
Mohammad Sayem
MBMartiniano Bello
Martiniano Bello
SMSadia Islam Mou
Sadia Islam Mou
NFNairita Ahsan Faruqui
Nairita Ahsan Faruqui
Md. Kamrul HasanMd. Kamrul Hasan
Md. Kamrul Hasan
Background: A variety of accessible data, including those of single-nucleotide polymorphisms (SNPs) on the human p53 gene, are made widely available on a global scale. Owing to this, our investigation aimed to deal with the detrimental SNPs in the p53 gene by executing various valid computational tools, including—Filter, SIFT, PredictSNP, Fathmm, UTRScan, ConSurf, SWISS-MODEL, Amber 16 package, Tm-Adjust, I-Mutant, Task Seek, GEPIA2 after practical and basic appraisal, dissolvable openness, atomic progression, analyzing the energy minimization and assessing the gene expression pattern. Results: Out of the total 581 p53 SNPs, 420 SNPs were found to be missense or non-synonymous, 435 SNPs were in the three prime UTR, and 112 SNPs were in the five prime UTR from which 16 non-synonymous SNPs (nsSNPs) were predicted to be non-tolerable while PredictSNP package predicted 14. Concentrating on six bioinformatics tools of various dimensions, a combined output was generated, where 14 nsSNPs could exert a deleterious effect. We found 5 missense SNPs in the DNA binding domain's three crucial amino acid positions, using diverse SNP analyzing tools. The underlying discoveries were fortified by microsecond molecular dynamics (MD) simulations, TM-align, I-Mutant, and Project HOPE. The ExPASy-PROSITE tools characterized whether the mutations were located in the functional part of the protein or not. This study provides a decisive outcome, concluding the accessible SNPs' information by recognizing the five unfavorable nsSNPs—rs28934573 (S241F), rs11540652 (R248Q), rs121913342 (R248W), rs121913343 (R273C), and rs28934576 (R273H). By utilizing Heatmapper and GEPIA2, several visualization plots, including heat maps, box plots, and survival plots, were produced. Conclusions: These plots disclosed differential expression patterns of the p53 gene in humans. The investigation focused on recognizing the detrimental nsSNPs, which augmented the danger posed by various oncogenesis in patients of different populations, including within the genome-wide studies (GWS).

30 June 2022 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
RRRazoan Al Rimon
Razoan Al Rimon
MSMohammad Sayem
Mohammad Sayem
SASaruar Alam
Saruar Alam
ASAbdullah Al Saba
Abdullah Al Saba
MSMousumi Sanyal
Mousumi Sanyal
ANA. H. M. Nurun Nabi
A. H. M. Nurun Nabi
The current study elucidated an association between gene variants and thrombocytopenia through the investigation of the exonic polymorphic landscape of hematopoietic transcription factor—GATA1 gene in dengue patients. A total of 115 unrelated dengue patients with dengue fever (DF) (N = 91) and dengue hemorrhagic fever (DHF) (N = 24) were included in the study. All dengue patients were confirmed through detection of NS1 antigen, IgM, and IgG antibodies against the dengue virus. Polymerase chain reaction using specific primers amplified the exonic regions of GATA1 while Sanger sequencing and chromatogram analyses facilitated the identification of variants. Variants G>A (at chX: 48792009) and C>A (at chX: 4879118) had higher frequency out of 13 variants identified (3 annotated and 10 newly recognized). Patients carrying either nonsynonymous or synonymous variants had significantly lower mean values of platelets compared to those harboring the reference nucleotides (NC_000023.11). Further analyses revealed that the change in amino acid residue leads to the altered three-dimensional structure followed by interaction with neighboring residues. Increased stability of the protein due to substitution of serine by asparagine (S129N at chX: 48792009) may cause increased rigidity followed by reduced structural flexibility which may ultimately disturb the dimerization (an important prerequisite for GATA1 to perform its biological activity) process of the GATA1 protein. This, in turn, may affect the function of GATA1 followed by impaired production of mature platelets which may be reflected by the lower platelet counts in individuals with such variation. In summary, we have identified new variants within the GATA1 gene which were found to be clinically relevant to the outcome of dengue patients and thus, have the potential as candidate biomarkers for the determination of severity and prognosis of thrombocytopenia caused by dengue virus. However, further validation of this study in a large number of dengue patients is warranted. Trial Registration: number SLCTR/2019/037.

30 March 2026 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
MFMohtasim Fuad
Mohtasim Fuad
SASadia Akter
Sadia Akter
ZMZimam Mahmud
Zimam Mahmud
STSonia Tamanna
Sonia Tamanna
MSMohammad Sayem
Mohammad Sayem
MHMd. Zakir Hossain Howlader
Md. Zakir Hossain Howlader
Transcription factor EB (TFEB) is an essential protein that is connected to a number of diseases, such as lysosomal storage disorders and cancer. Patients with glioblastoma multiforme and uterine endometrioid carcinoma have already been identified to have nonsynonymous mutations in this gene. These mutations may have an impact on TFEB protein's functions and structure. Therefore, to find possible biomarkers for different disease treatments, the most harmful single nucleotide polymorphisms (SNPs) of the TFEBprotein have been identified in this study. The goal is to create a systematic dataset of the SNPs related to the TFEBgene, which could be useful in the diagnosis and management of many disorders linked to the target gene. The SNPs of the TFEBprotein were analyzed via a wide range of bioinformatics techniques, including both sequence and structure-based methodologies. Nonsynonymous SNV research can be advanced through the application of various machine learning methods that have been developed as a result of recent advancements in computational platforms. Among 449 nsSNPs, a total of 6 nsSNPs have been found to be harmful, destabilizing, and disease-causing. Each nsSNP interferes with its function. All of the mutant proteins interact with the DNA molecule during docking more effectively than the alphafold (wild type) protein does. A strong correlation between cancer and mutations in R315 has been identified. The detrimental effects of nsSNPs and noncoding SNPs on the structure and activities of proteins will help researchers understand the crucial role that mutations play in the molecular pathways involved in a variety of disorders. The discovery of possible targets for the diagnosis of diseases and treatment interventions will eventually result from this. Moreover, this thorough analysis can facilitate the exploration of potential disease-causing SNPs in the TFEB gene and assist in identifying effective drugs or pharmacological targets. Consequently, further experimental mutational research, genome-wide association studies, and clinical-based studies are essential to validate these findings.

15 July 2025 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
MRMohammad Mamunur Rashid
Mohammad Mamunur Rashid
MSMohammad Sayem
Mohammad Sayem
MAMaisha Adiba
Maisha Adiba
ASAbdullah Al Saba
Abdullah Al Saba
ANA.H.M. Nurun Nabi
A.H.M. Nurun Nabi
TYTahirah Yasmin
Tahirah Yasmin
Type 2 diabetes (T2D) is a multifaceted disease influenced by both genetic and environmental factors, posing significant global health challenges. Polymorphisms in the SLC2A4 gene encoding the glucose transporter 4 (GLUT4), have been linked to insulin resistance and T2D. This study, therefore, aims to identify and analyze genetic variants within the SLC2A4 gene and determine their association with T2D risk through a Bangladeshi case-control study. A total of 239 individuals were enrolled in the study, including 127 T2D patients and 112 controls. All 11 exons of the SLC2A4 gene were sequenced in 20 individuals. Exons 2, 3, 4, and 5 of GLUT4 were then sequenced in an additional 99 participants. For the remaining 120 participants, a TaqMan probe-based RT-PCR was conducted to genotype rs5435. Four genetic variants were initially identified, including one synonymous variant (rs5435) in exon 4. There was no significant difference in the allele frequency of the wild-type allele T and variant allele C between the two groups (OR: 1.31, p = 0.13). Genotypic distribution revealed that individuals who were either heterozygous or homozygous for the variant allele are at an increased risk for developing T2D compared to those who are homozygous for the non-risk allele (p = 0.042), suggesting that the SNP could be considered to have a dominant effect on the likelihood of developing T2D. Additionally, in silico analysis revealed that the rs5435 variant introduces an additional loop in the mRNA secondary structure, which is energetically less stable and therefore may interfere with the protein's biological function and play a role in the pathogenesis of T2D. However, further studies with larger cohorts are necessary to validate the impact of rs5435 on the risk of T2D in our population.